相关实验视频
Updated: May 13, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.4K
利用基因组脱乙酶抑制剂来增强癌症免疫治疗
Fatemeh Hedayat1, Elnaz Faghfuri2
1Department of Biology, University of Mohaghegh Ardabili, Ardabil, Iran.
European journal of pharmacology
|April 16, 2025
概括
基因组脱乙酶抑制剂 (HDACis) 是一种表观遗传药物,可以帮助免疫系统对抗癌症. 将HDACis与免疫治疗结合使用可能会改善抗瘤效果并克服药物耐药性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 癌症通常会抑制免疫反应,帮助瘤生长和转移.
- 重新激活免疫系统对抗癌症提供了显著的治疗潜力.
- 基因组脱乙酶抑制剂 (HDACis) 是一类向疗法,通过表观遗传修饰调节免疫反应.
研究的目的:
- 审查不同类型的HDAC如何影响免疫系统.
- 探索最近在将HDACis与新型免疫疗法结合方面的进展.
- 总结了体外,体内和临床研究中的发现.
主要方法:
- 关于HDACis和癌症免疫治疗的体外,体内和临床研究的文献综述.
- 对HDACs影响抗癌免疫反应的机制的分析.
- 检查涉及HDACis和免疫疗法的新兴组合策略.
主要成果:
- 通过放松染色质,提高DNA可访问性,HDACis可以提高癌症治疗效率.
- 这些抑制剂可以破坏癌症DNA修复机制,并提高免疫检查点受体的调节.
- 有证据表明,HDACs调节与抗瘤活性相关的各种免疫细胞功能.
结论:
- HDACis代表了一种有希望的表观遗传策略,以增强抗癌免疫力.
- 将HDACis与免疫治疗结合起来,有可能改善抗瘤结果.
- 对HDACi和免疫疗法组合的进一步研究可能会克服治疗耐药性.
相关概念视频
Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
Cancer Vaccines
251
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
251
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K

